WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001030759) SODIUM-HYDROGEN EXCHANGER TYPE 1 INHIBITOR CRYSTALS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/030759    International Application No.:    PCT/IB2000/001460
Publication Date: 03.05.2001 International Filing Date: 09.10.2000
Chapter 2 Demand Filed:    08.02.2001    
IPC:
C07D 401/04 (2006.01)
Applicants: PFIZER PRODUCTS INC. [US/US]; Eastern Point Road, Groton, CT 06340 (US) (For All Designated States Except US).
BROSTROM, Lyle, Robinson [US/US]; (US) (For US Only).
CONNOLLY, Terrence, Joseph [CA/CA]; (CA) (For US Only).
LI, Zheng, Jane [US/US]; (US) (For US Only).
ORRILL, Susan, Lee [US/US]; (US) (For US Only).
SHAH, Bharat, Kiritkumar [US/US]; (US) (For US Only)
Inventors: BROSTROM, Lyle, Robinson; (US).
CONNOLLY, Terrence, Joseph; (CA).
LI, Zheng, Jane; (US).
ORRILL, Susan, Lee; (US).
SHAH, Bharat, Kiritkumar; (US)
Agent: SPIEGEL, Allen, J.; Pfizer Inc., 235 East 42nd Street, New York, NY 10017 (US)
Priority Data:
60/162,374 29.10.1999 US
Title (EN) SODIUM-HYDROGEN EXCHANGER TYPE 1 INHIBITOR CRYSTALS
(FR) CRISTAUX D'INHIBITEURS DE L'ECHANGEUR SODIUM-HYDROGENE DE TYPE 1
Abstract: front page image
(EN)NHE-1 inhibitor crystal of Formula (I), methods of using such NHE-1 inhibitor crystal and pharmaceutical compositions containing such NHE-1 inhibitor crystal. The NHE-1 inhibitor crystal is useful for the reduction of tissue damage resulting from tissue ischemia.
(FR)L'invention concerne des cristaux d'inhibiteurs de l'échangeur sodium-hydrogène de type 1 (NHE-1), les méthodes d'utilisation desdits cristaux d'inhibiteurs NHE-1, et des compositions pharmaceutiques renfermant les cristaux d'inhibiteurs NHE-1. Ces cristaux d'inhibiteurs NHE-1 sont utilisés pour limiter les lésions tissulaires résultant de l'ischémie tissulaire.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)